An express license for this technology is available via JHTV's online licensing portal.
PROVAM was developed to assess symptoms, functional limitations, and social/emotional effects experienced by patients with low-flow vascular malformations (VMs). The 30-item instrument assesses the domains of pain, emotional/social well-being, functional impact, and treatment satisfaction. Two additional items assess ease of understanding and relevance. PROVAM is responsive to improvement after treatment and may be useful to assess health-related quality of life in patients treated for VMs.
